Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment
Keywords: Antitumor effect; Bone cancer; Lectin; Mesoporous silica nanoparticles; Nanomedicine; pH-responsive drug release; Synergistic combination; Targeting;